CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

IPSCCentury Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.71 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$309.64M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-15 · Carr Douglas (SVP Finance & Operations) · SELL
  • 2026-09-15 · Russotti Gregory (See Remarks) · SELL
  • 2026-09-15 · Pfeiffenberger Brent (President and CEO) · OTHER
  • 2026-09-09 · Russotti Gregory (See Remarks) · SELL
  • 2026-09-09 · Carr Douglas (SVP Finance & Operations) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders107
Shares held168,349,701
Value$403.90M
Percent of shares outstanding92.97%
As of quarter end2026-06-30
RECENT NEWS
  • Century Therapeutics presents diabetes therapy data at EASD
  • Century Therapeutics presents preclinical data for T1D therapy
  • Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
  • Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet
  • Century Therapeutics CTO Gregory Russotti sells $4,992 in stock
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS